A Saphir. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Abnormalities, Drug-InducedAcquired Immunodeficiency Syndrome/complicationsAntineoplastic AgentsClinical Trials, Phase II as TopicFemaleHumansLegislation, DrugPregnancySarcoma, Kaposi/drug therapyThalidomide/adverse effectsThalidomide/therapeutic useUnited States
Substances： See more » Antineoplastic AgentsThalidomide
Year: 1997 PMID： 9337341
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506